Effects of wortmannin on bronchoconstrictor responses to adenosine in actively sensitised Brown Norway rats
The bronchoconstrictor response to adenosine in the actively sensitised Brown Norway rat is markedly augmented following low level allergen (ovalbumin) challenge. The response reflects activation of the A 2B receptor subtype and is mediated by 5-hydroxytryptamine (5-HT) released as a consequence of...
Gespeichert in:
Veröffentlicht in: | European journal of pharmacology 2000-10, Vol.406 (3), p.469-476 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 476 |
---|---|
container_issue | 3 |
container_start_page | 469 |
container_title | European journal of pharmacology |
container_volume | 406 |
creator | Tigani, Bruno Hannon, Jason P Mazzoni, Lazzaro Fozard, John R |
description | The bronchoconstrictor response to adenosine in the actively sensitised Brown Norway rat is markedly augmented following low level allergen (ovalbumin) challenge. The response reflects activation of the A
2B receptor subtype and is mediated by 5-hydroxytryptamine (5-HT) released as a consequence of mast cell activation. We describe here the effects of wortmannin, a potent inhibitor of phosphatidylinositol-3-kinase and mast cell exocytosis, on the response to adenosine. Bronchoconstrictor responses to adenosine elicited 3 h following ovalbumin challenge were markedly and dose-dependently reduced by wortmannin given intratracheally (i.t.), 1 h prior to or 2 h post-allergen challenge. Responses to methacholine, which activates bronchial smooth muscle directly, and 5-HT were also reduced following wortmannin but to a lesser extent than those to adenosine. Bronchoconstrictor responses to adenosine 3 h post-challenge with vehicle were also markedly reduced by wortmannin given intratracheally (i.t.), 1 h prior to the “sham” challenge. Plasma histamine and 5-HT levels increased in response to adenosine given 3 h following ovalbumin challenge. The increases were suppressed by wortmannin given i.t., 2 h post-ovalbumin challenge. A reduction in the sensitivity of the airways to 5-HT explains in part the reduced bronchoconstrictor response to adenosine induced by wortmannin. A direct action to suppress 5-HT release from airway mast cells induced by adenosine also contributes to the reduction in the response. Inhibition of phosphatidylinositol-3-kinase is the presumed mechanistic basis for the observed effects. |
doi_str_mv | 10.1016/S0014-2999(00)00705-6 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_72350811</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0014299900007056</els_id><sourcerecordid>72350811</sourcerecordid><originalsourceid>FETCH-LOGICAL-c390t-a2956956fc1159187648810e282601025d8380b0b945f4398734f2554bf375f53</originalsourceid><addsrcrecordid>eNqFkcGKFDEQQIMo7uzqJyg5iOihtZJ0ujsn0WVXhUUP6jmk0xWM9iRjKrPD_L09O4N7FAqKgldVySvGngl4I0B0b78BiLaRxphXAK8BetBN94CtxNCbBnohH7LVP-SMnRP9AgBtpH7MzoSAFpTWK_b7KgT0lXgOfJdLXbuUYuI58bHk5H9mnxPVEn3NhRekzVIi8Zq5mzBlign5wjtf4y3Oe06YKNZIOPEPJe8S_5LLzu15cZWesEfBzYRPT_mC_bi--n75qbn5-vHz5fubxisDtXHS6G6J4IXQZvlP1w6DAJSD7ECA1NOgBhhhNK0OrTJDr9ogtW7HoHodtLpgL49zNyX_2SJVu47kcZ5dwrwl20ulYRBiAfUR9CUTFQx2U-Lalb0VYA-W7Z1le1BoAeydZdstfc9PC7bjGqf7rpPWBXhxAhx5N4fiko90z2klTHfA3h0xXGzcRiyWfMTkcYplOYqdcvzPS_4CzY2Y4w</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>72350811</pqid></control><display><type>article</type><title>Effects of wortmannin on bronchoconstrictor responses to adenosine in actively sensitised Brown Norway rats</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Tigani, Bruno ; Hannon, Jason P ; Mazzoni, Lazzaro ; Fozard, John R</creator><creatorcontrib>Tigani, Bruno ; Hannon, Jason P ; Mazzoni, Lazzaro ; Fozard, John R</creatorcontrib><description>The bronchoconstrictor response to adenosine in the actively sensitised Brown Norway rat is markedly augmented following low level allergen (ovalbumin) challenge. The response reflects activation of the A
2B receptor subtype and is mediated by 5-hydroxytryptamine (5-HT) released as a consequence of mast cell activation. We describe here the effects of wortmannin, a potent inhibitor of phosphatidylinositol-3-kinase and mast cell exocytosis, on the response to adenosine. Bronchoconstrictor responses to adenosine elicited 3 h following ovalbumin challenge were markedly and dose-dependently reduced by wortmannin given intratracheally (i.t.), 1 h prior to or 2 h post-allergen challenge. Responses to methacholine, which activates bronchial smooth muscle directly, and 5-HT were also reduced following wortmannin but to a lesser extent than those to adenosine. Bronchoconstrictor responses to adenosine 3 h post-challenge with vehicle were also markedly reduced by wortmannin given intratracheally (i.t.), 1 h prior to the “sham” challenge. Plasma histamine and 5-HT levels increased in response to adenosine given 3 h following ovalbumin challenge. The increases were suppressed by wortmannin given i.t., 2 h post-ovalbumin challenge. A reduction in the sensitivity of the airways to 5-HT explains in part the reduced bronchoconstrictor response to adenosine induced by wortmannin. A direct action to suppress 5-HT release from airway mast cells induced by adenosine also contributes to the reduction in the response. Inhibition of phosphatidylinositol-3-kinase is the presumed mechanistic basis for the observed effects.</description><identifier>ISSN: 0014-2999</identifier><identifier>EISSN: 1879-0712</identifier><identifier>DOI: 10.1016/S0014-2999(00)00705-6</identifier><identifier>PMID: 11040355</identifier><identifier>CODEN: EJPHAZ</identifier><language>eng</language><publisher>Amsterdam: Elsevier B.V</publisher><subject>5-HT ; Active sensitisation ; Adenosine ; Adenosine - pharmacology ; Androstadienes - pharmacology ; Animals ; Biological and medical sciences ; Bronchi - drug effects ; Bronchi - physiology ; Bronchoconstriction ; Brown Norway ; Chronic obstructive pulmonary disease, asthma ; Enzyme Inhibitors - pharmacology ; Histamine - blood ; Male ; Medical sciences ; Methacholine ; Methacholine Chloride - pharmacology ; Ovalbumin ; Ovalbumin - immunology ; Pharmacology. Drug treatments ; Phosphatidylinositol 3-Kinases - antagonists & inhibitors ; Phosphatidylinositol-3-kinase ; Pneumology ; rat ; Rats ; Rats, Inbred BN ; Respiratory system ; Serotonin - blood ; Serotonin - pharmacology ; Wortmannin</subject><ispartof>European journal of pharmacology, 2000-10, Vol.406 (3), p.469-476</ispartof><rights>2000 Elsevier Science B.V.</rights><rights>2000 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c390t-a2956956fc1159187648810e282601025d8380b0b945f4398734f2554bf375f53</citedby><cites>FETCH-LOGICAL-c390t-a2956956fc1159187648810e282601025d8380b0b945f4398734f2554bf375f53</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0014299900007056$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=1531965$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11040355$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Tigani, Bruno</creatorcontrib><creatorcontrib>Hannon, Jason P</creatorcontrib><creatorcontrib>Mazzoni, Lazzaro</creatorcontrib><creatorcontrib>Fozard, John R</creatorcontrib><title>Effects of wortmannin on bronchoconstrictor responses to adenosine in actively sensitised Brown Norway rats</title><title>European journal of pharmacology</title><addtitle>Eur J Pharmacol</addtitle><description>The bronchoconstrictor response to adenosine in the actively sensitised Brown Norway rat is markedly augmented following low level allergen (ovalbumin) challenge. The response reflects activation of the A
2B receptor subtype and is mediated by 5-hydroxytryptamine (5-HT) released as a consequence of mast cell activation. We describe here the effects of wortmannin, a potent inhibitor of phosphatidylinositol-3-kinase and mast cell exocytosis, on the response to adenosine. Bronchoconstrictor responses to adenosine elicited 3 h following ovalbumin challenge were markedly and dose-dependently reduced by wortmannin given intratracheally (i.t.), 1 h prior to or 2 h post-allergen challenge. Responses to methacholine, which activates bronchial smooth muscle directly, and 5-HT were also reduced following wortmannin but to a lesser extent than those to adenosine. Bronchoconstrictor responses to adenosine 3 h post-challenge with vehicle were also markedly reduced by wortmannin given intratracheally (i.t.), 1 h prior to the “sham” challenge. Plasma histamine and 5-HT levels increased in response to adenosine given 3 h following ovalbumin challenge. The increases were suppressed by wortmannin given i.t., 2 h post-ovalbumin challenge. A reduction in the sensitivity of the airways to 5-HT explains in part the reduced bronchoconstrictor response to adenosine induced by wortmannin. A direct action to suppress 5-HT release from airway mast cells induced by adenosine also contributes to the reduction in the response. Inhibition of phosphatidylinositol-3-kinase is the presumed mechanistic basis for the observed effects.</description><subject>5-HT</subject><subject>Active sensitisation</subject><subject>Adenosine</subject><subject>Adenosine - pharmacology</subject><subject>Androstadienes - pharmacology</subject><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Bronchi - drug effects</subject><subject>Bronchi - physiology</subject><subject>Bronchoconstriction</subject><subject>Brown Norway</subject><subject>Chronic obstructive pulmonary disease, asthma</subject><subject>Enzyme Inhibitors - pharmacology</subject><subject>Histamine - blood</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Methacholine</subject><subject>Methacholine Chloride - pharmacology</subject><subject>Ovalbumin</subject><subject>Ovalbumin - immunology</subject><subject>Pharmacology. Drug treatments</subject><subject>Phosphatidylinositol 3-Kinases - antagonists & inhibitors</subject><subject>Phosphatidylinositol-3-kinase</subject><subject>Pneumology</subject><subject>rat</subject><subject>Rats</subject><subject>Rats, Inbred BN</subject><subject>Respiratory system</subject><subject>Serotonin - blood</subject><subject>Serotonin - pharmacology</subject><subject>Wortmannin</subject><issn>0014-2999</issn><issn>1879-0712</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2000</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkcGKFDEQQIMo7uzqJyg5iOihtZJ0ujsn0WVXhUUP6jmk0xWM9iRjKrPD_L09O4N7FAqKgldVySvGngl4I0B0b78BiLaRxphXAK8BetBN94CtxNCbBnohH7LVP-SMnRP9AgBtpH7MzoSAFpTWK_b7KgT0lXgOfJdLXbuUYuI58bHk5H9mnxPVEn3NhRekzVIi8Zq5mzBlign5wjtf4y3Oe06YKNZIOPEPJe8S_5LLzu15cZWesEfBzYRPT_mC_bi--n75qbn5-vHz5fubxisDtXHS6G6J4IXQZvlP1w6DAJSD7ECA1NOgBhhhNK0OrTJDr9ogtW7HoHodtLpgL49zNyX_2SJVu47kcZ5dwrwl20ulYRBiAfUR9CUTFQx2U-Lalb0VYA-W7Z1le1BoAeydZdstfc9PC7bjGqf7rpPWBXhxAhx5N4fiko90z2klTHfA3h0xXGzcRiyWfMTkcYplOYqdcvzPS_4CzY2Y4w</recordid><startdate>20001020</startdate><enddate>20001020</enddate><creator>Tigani, Bruno</creator><creator>Hannon, Jason P</creator><creator>Mazzoni, Lazzaro</creator><creator>Fozard, John R</creator><general>Elsevier B.V</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20001020</creationdate><title>Effects of wortmannin on bronchoconstrictor responses to adenosine in actively sensitised Brown Norway rats</title><author>Tigani, Bruno ; Hannon, Jason P ; Mazzoni, Lazzaro ; Fozard, John R</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c390t-a2956956fc1159187648810e282601025d8380b0b945f4398734f2554bf375f53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2000</creationdate><topic>5-HT</topic><topic>Active sensitisation</topic><topic>Adenosine</topic><topic>Adenosine - pharmacology</topic><topic>Androstadienes - pharmacology</topic><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Bronchi - drug effects</topic><topic>Bronchi - physiology</topic><topic>Bronchoconstriction</topic><topic>Brown Norway</topic><topic>Chronic obstructive pulmonary disease, asthma</topic><topic>Enzyme Inhibitors - pharmacology</topic><topic>Histamine - blood</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Methacholine</topic><topic>Methacholine Chloride - pharmacology</topic><topic>Ovalbumin</topic><topic>Ovalbumin - immunology</topic><topic>Pharmacology. Drug treatments</topic><topic>Phosphatidylinositol 3-Kinases - antagonists & inhibitors</topic><topic>Phosphatidylinositol-3-kinase</topic><topic>Pneumology</topic><topic>rat</topic><topic>Rats</topic><topic>Rats, Inbred BN</topic><topic>Respiratory system</topic><topic>Serotonin - blood</topic><topic>Serotonin - pharmacology</topic><topic>Wortmannin</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tigani, Bruno</creatorcontrib><creatorcontrib>Hannon, Jason P</creatorcontrib><creatorcontrib>Mazzoni, Lazzaro</creatorcontrib><creatorcontrib>Fozard, John R</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tigani, Bruno</au><au>Hannon, Jason P</au><au>Mazzoni, Lazzaro</au><au>Fozard, John R</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effects of wortmannin on bronchoconstrictor responses to adenosine in actively sensitised Brown Norway rats</atitle><jtitle>European journal of pharmacology</jtitle><addtitle>Eur J Pharmacol</addtitle><date>2000-10-20</date><risdate>2000</risdate><volume>406</volume><issue>3</issue><spage>469</spage><epage>476</epage><pages>469-476</pages><issn>0014-2999</issn><eissn>1879-0712</eissn><coden>EJPHAZ</coden><abstract>The bronchoconstrictor response to adenosine in the actively sensitised Brown Norway rat is markedly augmented following low level allergen (ovalbumin) challenge. The response reflects activation of the A
2B receptor subtype and is mediated by 5-hydroxytryptamine (5-HT) released as a consequence of mast cell activation. We describe here the effects of wortmannin, a potent inhibitor of phosphatidylinositol-3-kinase and mast cell exocytosis, on the response to adenosine. Bronchoconstrictor responses to adenosine elicited 3 h following ovalbumin challenge were markedly and dose-dependently reduced by wortmannin given intratracheally (i.t.), 1 h prior to or 2 h post-allergen challenge. Responses to methacholine, which activates bronchial smooth muscle directly, and 5-HT were also reduced following wortmannin but to a lesser extent than those to adenosine. Bronchoconstrictor responses to adenosine 3 h post-challenge with vehicle were also markedly reduced by wortmannin given intratracheally (i.t.), 1 h prior to the “sham” challenge. Plasma histamine and 5-HT levels increased in response to adenosine given 3 h following ovalbumin challenge. The increases were suppressed by wortmannin given i.t., 2 h post-ovalbumin challenge. A reduction in the sensitivity of the airways to 5-HT explains in part the reduced bronchoconstrictor response to adenosine induced by wortmannin. A direct action to suppress 5-HT release from airway mast cells induced by adenosine also contributes to the reduction in the response. Inhibition of phosphatidylinositol-3-kinase is the presumed mechanistic basis for the observed effects.</abstract><cop>Amsterdam</cop><pub>Elsevier B.V</pub><pmid>11040355</pmid><doi>10.1016/S0014-2999(00)00705-6</doi><tpages>8</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0014-2999 |
ispartof | European journal of pharmacology, 2000-10, Vol.406 (3), p.469-476 |
issn | 0014-2999 1879-0712 |
language | eng |
recordid | cdi_proquest_miscellaneous_72350811 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | 5-HT Active sensitisation Adenosine Adenosine - pharmacology Androstadienes - pharmacology Animals Biological and medical sciences Bronchi - drug effects Bronchi - physiology Bronchoconstriction Brown Norway Chronic obstructive pulmonary disease, asthma Enzyme Inhibitors - pharmacology Histamine - blood Male Medical sciences Methacholine Methacholine Chloride - pharmacology Ovalbumin Ovalbumin - immunology Pharmacology. Drug treatments Phosphatidylinositol 3-Kinases - antagonists & inhibitors Phosphatidylinositol-3-kinase Pneumology rat Rats Rats, Inbred BN Respiratory system Serotonin - blood Serotonin - pharmacology Wortmannin |
title | Effects of wortmannin on bronchoconstrictor responses to adenosine in actively sensitised Brown Norway rats |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T06%3A03%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effects%20of%20wortmannin%20on%20bronchoconstrictor%20responses%20to%20adenosine%20in%20actively%20sensitised%20Brown%20Norway%20rats&rft.jtitle=European%20journal%20of%20pharmacology&rft.au=Tigani,%20Bruno&rft.date=2000-10-20&rft.volume=406&rft.issue=3&rft.spage=469&rft.epage=476&rft.pages=469-476&rft.issn=0014-2999&rft.eissn=1879-0712&rft.coden=EJPHAZ&rft_id=info:doi/10.1016/S0014-2999(00)00705-6&rft_dat=%3Cproquest_cross%3E72350811%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=72350811&rft_id=info:pmid/11040355&rft_els_id=S0014299900007056&rfr_iscdi=true |